Vericel Corp

Biotechnology company · Burlington, Massachusetts, United States · Nasdaq: VCEL

Vericel Corp is a biotechnology company headquartered in Burlington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker VCEL. The US FDA lists 1 medical device site and 2 drug manufacturing or testing sites registered to the company, with devices in general and plastic surgery, orthopedic and pathology. It has received 24 US government small-business research awards (SBIR/STTR) from health agencies, $6 million in total, most recently in 2005. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Vericel at a glance

Typebiotechnology company
HeadquartersBurlington, Massachusetts, United States
Stock listingNasdaq: VCEL
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites3
SEC CIK887359

What does Vericel do?

Medical specialties of its FDA-listed devices

General and Plastic SurgeryOrthopedicPathologyGeneral HospitalHematologyClinical Chemistry

Device types listed with the FDA

TampAccessories, arthroscopicContainer, specimen mailer and storage, temperature controlled, sterilePasserCutter, surgicalSterilization wrap containers, trays, cassettes & other accessoriesMedia and components, synthetic cell and tissue cultureTape, measuring, rulers and calipers

Operations at its FDA-registered drug sites

AnalysisAPI manufacturingLabelingManufacturingPacking

US government research funding

24 SBIR/STTR small-business research awards from US health agencies, $6 million in total (1993 to 2005).

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $40 million sold (2012).

Where is Vericel located?

Headquarters: Burlington, Massachusetts, United States

  • Cambridge, MassachusettsVericel Corporation · FDA device and drug site
  • Burlington, MassachusettsVericel Corporation · FDA drug site

Frequently asked questions about Vericel

Where is Vericel headquartered?

Vericel Corp is headquartered in Burlington, Massachusetts, United States.

What does Vericel do?

Vericel Corp is a biotechnology company. Its FDA-listed medical devices fall under general and plastic surgery, orthopedic and pathology. Its FDA-registered drug sites are registered for analysis, API manufacturing, labeling and manufacturing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Vericel a public company?

Yes. Vericel Corp trades on Nasdaq under the ticker VCEL.

How many FDA-registered sites does Vericel have?

The US FDA lists 3 registered sites for Vericel Corp.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes